Source: EIN Presswire

Press Release: Vidac Pharma : Vidac Pharma Reports Exceptional Pharmacokinetics of Almavid Drug Candidate in Real-World Clinical study

Revolutionary cancer treatment demonstrates potential for Almavid Drug Candidate application in solid tumors. Vidac pharma Holding Plc (XSTU:SYM: T9G; ISIN: GB00BM9XQ619; WKN: A3DTUQ) LONDON, UNITED KINGDOM, May 28, 2025 /⁨EINPresswire.com⁩/ -- Vidac ...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Oren M. Becker's photo - President & CEO of Vidac Pharma

President & CEO

Oren M. Becker

CEO Approval Rating

69/100

Read more